Literature DB >> 16840316

Resistance of mRNA translation to acute endoplasmic reticulum stress-inducing agents in herpes simplex virus type 1-infected cells requires multiple virus-encoded functions.

Matthew Mulvey1, Carolina Arias, Ian Mohr.   

Abstract

Via careful control of multiple kinases that inactivate the critical translation initiation factor eIF2 by phosphorylation of its alpha subunit, the cellular translation machinery can rapidly respond to a spectrum of environmental stresses, including viral infection. Indeed, virus replication produces a battery of stresses, such as endoplasmic reticulum (ER) stress resulting from misfolded proteins accumulating within the lumen of this organelle, which could potentially result in eIF2alpha phosphorylation and inhibit translation. While cellular translation is exquisitely sensitive to ER stress-inducing agents, protein synthesis in herpes simplex virus type 1 (HSV-1)-infected cells is notably resistant. Sustained translation in HSV-1-infected cells exposed to acute ER stress does not involve the interferon-induced, double-stranded RNA-responsive eIF2alpha kinase PKR, and it does not require either the PKR inhibitor encoded by the Us11 gene or the eIF2alpha phosphatase component specified by the gamma(1)34.5 gene, the two viral functions known to regulate eIF2alpha phosphorylation. In addition, although ER stress potently induced the GADD34 cellular eIF2alpha phosphatase subunit in uninfected cells, it did not accumulate to detectable levels in HSV-1-infected cells under identical exposure conditions. Significantly, resistance of translation to the acute ER stress observed in infected cells requires HSV-1 gene expression. Whereas blocking entry into the true late phase of the viral developmental program does not abrogate ER stress-resistant translation, the presence of viral immediate-early proteins is sufficient to establish a state permissive of continued polypeptide synthesis in the presence of ER stress-inducing agents. Thus, one or more previously uncharacterized viral functions exist to counteract the accumulation of phosphorylated eIF2alpha in response to ER stress in HSV-1-infected cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840316      PMCID: PMC1563692          DOI: 10.1128/JVI.00479-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response.

Authors:  Hong-Lin Su; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions.

Authors:  M T Sciortino; M Suzuki; B Taddeo; B Roizman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease.

Authors:  David N Everly; Pinghui Feng; I Saira Mian; G Sullivan Read
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and gamma(1)34.5 gene products.

Authors:  Matthew Mulvey; Vladimir Camarena; Ian Mohr
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Changes in BiP (GRP78) levels upon HSV-1 infection are strain dependent.

Authors:  H Mao; D Palmer; K S Rosenthal
Journal:  Virus Res       Date:  2001-08       Impact factor: 3.303

6.  Pancreatic eukaryotic initiation factor-2alpha kinase (PEK) homologues in humans, Drosophila melanogaster and Caenorhabditis elegans that mediate translational control in response to endoplasmic reticulum stress.

Authors:  R Sood; A C Porter; K Ma; L A Quilliam; R C Wek
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

7.  mRNA decay during herpesvirus infections: interaction between a putative viral nuclease and a cellular translation factor.

Authors:  P Feng; D N Everly; G S Read
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR.

Authors:  Nicole Pavio; Deborah R Taylor; Michael M C Lai
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway.

Authors:  Keith D Tardif; Kazutoshi Mori; Aleem Siddiqui
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.

Authors:  John M Lubinski; Ming Jiang; Lauren Hook; Yueh Chang; Chad Sarver; Dimitrios Mastellos; John D Lambris; Gary H Cohen; Roselyn J Eisenberg; Harvey M Friedman
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  14 in total

1.  Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection.

Authors:  Heather F Burnett; Timothy E Audas; Genqing Liang; Rui Ray Lu
Journal:  Cell Stress Chaperones       Date:  2012-01-20       Impact factor: 3.667

2.  Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor.

Authors:  Matthew Mulvey; Carolina Arias; Ian Mohr
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Herpes simplex virus 2 infection impacts stress granule accumulation.

Authors:  Renée L Finnen; Kyle R Pangka; Bruce W Banfield
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Poly(A)-binding protein 1 partially relocalizes to the nucleus during herpes simplex virus type 1 infection in an ICP27-independent manner and does not inhibit virus replication.

Authors:  C Salaun; A I MacDonald; O Larralde; L Howard; K Lochtie; H M Burgess; M Brook; P Malik; N K Gray; S V Graham
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

5.  mRNA decay during herpes simplex virus (HSV) infections: mutations that affect translation of an mRNA influence the sites at which it is cleaved by the HSV virion host shutoff (Vhs) protein.

Authors:  Lora A Shiflett; G Sullivan Read
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

6.  Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix.

Authors:  Mark E Lauer; Durba Mukhopadhyay; Csaba Fulop; Carol A de la Motte; Alana K Majors; Vincent C Hascall
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

7.  Increased eIF2alpha phosphorylation attenuates replication of herpes simplex virus 2 vhs mutants in mouse embryonic fibroblasts and correlates with reduced accumulation of the PKR antagonist ICP34.5.

Authors:  Kristine M Wylie; Jane E Schrimpf; Lynda A Morrison
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

Review 8.  Cellular unfolded protein response against viruses used in gene therapy.

Authors:  Dwaipayan Sen; Balaji Balakrishnan; Giridhara R Jayandharan
Journal:  Front Microbiol       Date:  2014-05-26       Impact factor: 5.640

9.  Biophysical Characterization of Nucleophosmin Interactions with Human Immunodeficiency Virus Rev and Herpes Simplex Virus US11.

Authors:  Kazem Nouri; Jens M Moll; Lech-Gustav Milroy; Anika Hain; Radovan Dvorsky; Ehsan Amin; Michael Lenders; Luitgard Nagel-Steger; Sebastian Howe; Sander H J Smits; Hartmut Hengel; Lutz Schmitt; Carsten Münk; Luc Brunsveld; Mohammad R Ahmadian
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

10.  Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.

Authors:  Mirko Kummer; Nadine M Turza; Petra Muhl-Zurbes; Matthias Lechmann; Chris Boutell; Robert S Coffin; Roger D Everett; Alexander Steinkasserer; Alexander T Prechtel
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.